摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7,8,17,18-tetrahydro-6H,16H-dibenzo{g,o}{1,9,5,13}dithiadiazacyclohexadecine | 1190197-33-1

中文名称
——
中文别名
——
英文名称
7,8,17,18-tetrahydro-6H,16H-dibenzo{g,o}{1,9,5,13}dithiadiazacyclohexadecine
英文别名
7,8,15,16-dibenzo-5,13-diaza-1,9-dithia-cyclotetradeca-5,13-diene;7,8,15,16-bisbenzo-5,13-diaza-1,9-dithia-cyclohexadecane;trans-(N-pr-S)2;trans-H4(N-pr-S)2;2,14-Dithia-6,18-diazatricyclo[18.4.0.08,13]tetracosa-1(24),6,8,10,12,18,20,22-octaene
7,8,17,18-tetrahydro-6H,16H-dibenzo{g,o}{1,9,5,13}dithiadiazacyclohexadecine化学式
CAS
1190197-33-1
化学式
C20H22N2S2
mdl
——
分子量
354.54
InChiKey
JXWGEBBKKUKJNE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    24
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    75.3
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • Structure and dynamic behaviour of palladium(II) complexes formed from trans-N2S2 macrocyclic ligands and the crystal structure of [PdL1][PF6]2(L1= 7,8,17,18-tetrahydro-6H, 16H-dibenzo[g,o][1,9,5,13]dithiadiazacyclohexadecine)
    作者:Julianna M. Csavas、Max R. Taylor、Kevin P. Wainwright
    DOI:10.1039/dt9880002573
    日期:——
    18-tetrahydro-6H, 16H-dibenzo[g,o][1,9,5,13]dithiadiazacyclohexadecine, L1, gives a complex with palladium(II) which exists in solution as an equilibrium mixture of two diastereomers, observable at low temperature by 13C n.m.r. The two diastereomers are meso and racemic forms of the complex related by inversion at one of the two sulphur stereocentres. They interconvert on the n.m.r. time-scale at elevated
    十六元反式-N 2 S 2大环7,8,17,18-四氢-6 H,16 H-二苯并[ g,o ] [1,9,5,13]二噻二氮杂环十六烷L 1给出络合物与(II)以两种非对映异构体的平衡混合物形式存在于溶液中,在低温下可通过13 C nmr观察到。这两种非对映异构体是内消旋体和外消旋体形式的络合物,通过在两个立体中心之一进行反演来实现。它们在高温下的nmr时间尺度上相互转换,ΔG ‡ = 63.3 kJ mol –1在288 K时测量。两组共振的相对强度的测量得出K = 0.36(外消旋→内消旋),在230-280 K的范围内温度基本不变。从乙腈-甲醇(4:1)混合物中结晶,作为PF 6 -的盐,产生已由示出了单个化合物X射线晶体学是内消旋非对映体,其中,所述的Pd原子在位于反演中心和扭曲正方形平面的几何形状,用Pd-S 2.307(1 )Å,Pd–N 2.047(4)Å,S–Pd–N(苯系螯合物环)84
  • Structural studies of trans-N2S2 copper macrocycles
    作者:Katherine D. Trotter、John Reglinski、Keith Robertson、John C. Forgie、John A. Parkinson、Alan R. Kennedy、David R. Armstrong、Rebecca J. Sowden、Corinne M. Spickett
    DOI:10.1016/j.ica.2009.05.060
    日期:2009.8
    The X-ray crystal structures of two related trans-N2S2 copper macrocycles are reported. One was isolated with the copper in the divalent form and the other with copper in its univalent form affording a valuable insight into the changes of geometry and metrical parameters that occur during redox processes in macrocyclic copper complexes. A variable temperature NMR study of the copper(I) complex is reported, indicative of a chair-boat conformational change within the alkyl chain backbone of the macrocycle. It was possible to extract the relevant kinetic and thermodynamic parameters (Delta G(double dagger), 57.8 kJ mol (1); Delta H-double dagger, 52.1 kJ mol(-1); Delta S-double dagger, -19.2 J K (1) mol (1)) for this process at 298 K. DFT molecular orbital calculations were used to confirm these observations and to calculate the energy difference (26.2 kJmol (1)) between the copper( I) macrocycle in a planar and a distorted tetrahedral disposition. (C) 2009 Elsevier B. V. All rights reserved.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)